Drug intelligence / Profile preview

technetium Tc 99m antimony trisulfide colloid

Development stage
Unknown
Lead developer
Isologic Innovative Radiopharmaceuticals
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Subcutaneous, Intradermal
01

Overview

Technetium Tc 99m antimony trisulfide colloid is a radiopharmaceutical diagnostic imaging agent primarily utilized for lymphoscintigraphy and the identification of sentinel lymph nodes in patients with solid tumors, such as breast cancer and melanoma. The agent consists of a colloidal suspension of antimony trisulfide particles labeled with the radioisotope technetium-99m ($^{99m}$Tc). Following interstitial (subcutaneous or intradermal) injection, the small particle size (typically ranging from 3 to 30 nm) allows for efficient migration through lymphatic channels to regional lymph nodes. Once in the nodes, the particles are sequestered by macrophages within the reticuloendothelial system. This localization enables the visualization of lymphatic drainage patterns and the precise identification of the first-draining (sentinel) node using gamma scintigraphy or SPECT imaging, which is critical for accurate surgical staging and biopsy.

Other names
antimony colloid sulfideantimony trisulfide colloid99mTc-antimony sulfide colloidtechnetium Tc 99m antimony sulfide colloid

Beyond the preview

Go deeper on technetium Tc 99m antimony trisulfide colloid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on technetium Tc 99m antimony trisulfide colloid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call